GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conformis Inc (NAS:CFMS) » Definitions » Cash, Cash Equivalents, Marketable Securities

Conformis (Conformis) Cash, Cash Equivalents, Marketable Securities : $26.18 Mil (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Conformis Cash, Cash Equivalents, Marketable Securities?

Conformis's quarterly cash, cash equivalents, marketable securities declined from Dec. 2022 ($48.67 Mil) to Mar. 2023 ($37.79 Mil) but then stayed the same from Mar. 2023 ($37.79 Mil) to Jun. 2023 ($26.18 Mil).

Conformis's annual cash, cash equivalents, marketable securities increased from Dec. 2020 ($28.67 Mil) to Dec. 2021 ($100.56 Mil) but then declined from Dec. 2021 ($100.56 Mil) to Dec. 2022 ($48.67 Mil).


Conformis Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Conformis's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conformis Cash, Cash Equivalents, Marketable Securities Chart

Conformis Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.63 26.39 28.67 100.56 48.67

Conformis Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.64 59.58 48.67 37.79 26.18

Conformis Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Conformis  (NAS:CFMS) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Conformis Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Conformis's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Conformis (Conformis) Business Description

Industry
Traded in Other Exchanges
N/A
Address
600 Technology Park Drive, Billerica, MA, USA, 01821
Conformis Inc is a United States-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
Executives
Christine Desrochers officer: Fmr Interim CFO & Controller 600 TECHNOLOGY PARK DRIVE, 4TH FLOOR, BILLERICA MA 01821
Gary P Fischetti director 600 TECHNOLOGY PARK DRIVE, 4TH FLOOR, BILLERICA MA 01821
Mark A Augusti director, officer: FORMER PRESIDENT & CEO 40 WEST HIGHLAND PARK DRIVE NE, HUTCHINSON MN 55350
Denise E Pedulla officer: FORMER CLO & SECRETARY 12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913
Philip W Johnston director C/O CONFORMIS INC, 600, BILLERICA MA 01821
Carrie Bienkowski director C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Robert S Howe officer: CFO & TREASURER C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
J Brent Alldredge officer: CLO & SECRETARY C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Fallon Kenneth P Iii director 5473 FOX HOLLOW DRIVE, NAPLES FL 34101
Erin Henry officer: CORP CONTROLLER & INTERIM PAO C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Frederick W Driscoll officer: INTERIM CFO & INTERIM TREAS
Paul S Weiner officer: Chief Financial Officer C/O CONFORMIS INC, 28 CROSBY DRIVE, BEDFORD MA 01730
Archon Capital Management Llc 10 percent owner 1100 19TH AVENUE EAST, SEATTLE WA 98112
Patricia A Davis officer: CLO & GENERAL COUNSEL C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 02181
Bradley Langdale director C/O CONFORMIS, INC., 28 CROSBY DRIVE, BEDFORD MA 01730